← Back to patent-cliff list
Fosnetupitant
Tier C — Watch / tradeFosnetupitant
Helsinn
Originator
2022
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：NK1R
Brand：Arokaris
Indications (approved)：Chemotherapy-induced nausea and vomiting
Regional status
US
-
EU
-
China
-
Japan
Approved
2022-03-28
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Fosnetupitant?
Approved indications include: Chemotherapy-induced nausea and vomiting.
When does the Fosnetupitant patent expire?
No public expiry year is available for Fosnetupitant yet; this page updates once verified.
How do I get a quote for Fosnetupitant intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01